All In Biotech

Drug Trial Radar · NCT00324571

Dialysis Clinical Outcomes Revisited (DCOR) Trial

A Randomized, Open Label, Parallel Design Study of Renagel® Phosphate Binder Versus Calcium-Based Phosphate Binders in Hemodialysis Patients

Last checked: Nov 20, 2026Latest source record: Mar 18, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 2,000 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,000

Actual

Start

Mar 2001

Primary completion

Not stated

Study completion Feb 2006

Sponsor

Lead sponsor
Genzyme, a Sanofi CompanySanofi (SNY)
Sponsor type
Industry
First posted
May 11, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, open-label, parallel-design study to be conducted at 75 centers within the United States. The study will be described to hemodialysis patients. Informed consent will be obtained and the inclusion/exclusion criteria reviewed. Eligible patients will be randomized to receive either Renagel or a calcium-based binder. Starting from the randomization date, mortality data including survival, death date and cause of death (vital status information) and morbidity data including hospitalization date will be recorded for all patients. These data will be collected until the end of the study (December 31, 2004, ± 2 weeks). Patients completing or terminating from the study will return to the phosphate binder prescribed by their usual healthcare provider.

Conditions

  • Chronic Kidney Disease

Interventions

  • Sevelamer hydrochlorideDrug

  • Calcium-based phosphate binderDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy will be evaluated based on a comparison of the association of Renagel use versus calcium-based phosphate binder use on all-cause mortality, cause-specific mortality (cardiovascular, infection, other), and all-cause hospitalization.
  2. Safety will be assessed based on an evaluation of related serious adverse events.

Locations

73 sites in 2 countries. Site status is shown where the registry gives one.

  • Gambro Healthcare-Gadsden

    Gadsden, Alabama

  • nTouch Research

    Huntsville, Alabama

  • Kidney Health Institute, LLC

    Tucson, Arizona

  • Gambro Healthcare

    El Cerrito, California

  • Palomar Medical Group

    Escondido, California

  • Gambro Healthcare-Los Angeles

    Los Angeles, California

  • Balboa Nephrology Medical Group

    San Diego, California

  • Nephrology Educational Services and Research

    Tarzana, California

  • Lowry Dialysis Center

    Denver, Colorado

  • Nephrology Associates, P.C.

    Bridgeport, Connecticut

  • Gambro Healthcare-Hartford

    Hartford, Connecticut

  • Nephrology Associates

    New Britain, Connecticut

  • InterAmerican Dialysis

    Coral Gables, Florida

  • DaVita Crystal River Dialysis

    Crystal River, Florida

  • Gambro Healthcare-Miami

    Miami, Florida

  • Miami Kidney Group

    Miami, Florida

  • Pensacola Nephrology, P.A.

    Pensacola, Florida

  • Gambro Healthcare-Plantation

    Plantation, Florida

  • America Dialysis

    St. Petersburg, Florida

  • Genesis Clinical Research Corp

    Tampa, Florida

  • Gambro Healthcare-Americus

    Americus, Georgia

  • nTouch Research

    Atlanta, Georgia

  • Gambro Healthcare-Douglas

    Douglas, Georgia

  • Gambro Healthcare-Douglasville

    Douglasville, Georgia

  • Dublin Nephrology

    Dublin, Georgia

  • Georgia Kidney Associates, Inc.

    Marietta, Georgia

  • Gambro Healthcare-Rome

    Rome, Georgia

  • Gambro Healthcare-Savannah

    Savannah, Georgia

  • MacNeal Renal Lifeline Services

    Berwyn, Illinois

  • Southwest Nephrology

    Evergreen Park, Illinois

  • Horizon Healthcare Associates

    Olympia Fields, Illinois

  • Renal Care Associates, S.C.

    Peoria, Illinois

  • Gambro Healthcare-Springfield Central

    Springfield, Illinois

  • Lincolnland Dialysis

    Springfield, Illinois

  • Nephrology Specialists, PC.

    Valparaiso, Indiana

  • Wichita Dialysis Center East

    Wichita, Kansas

  • Wichita Nephrology

    Wichita, Kansas

  • Northwest Louisiana Nephrology, LLC.

    Shreveport, Louisiana

  • BMA of Washington

    Bethesda, Maryland

  • Gambro Healthcare-Frederick

    Frederick, Maryland

Showing 40 of 73 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.